Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

POST-APPROVAL STUDY of TRANSCAROTID ARTERY REVASCULARIZATION in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE. The ROADSTER 2 Study.

NCT02536378 is registered in ClinicalTrials.gov with Silk Road Medical as lead sponsor.

NCT NCT02536378
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02536378 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
POST-APPROVAL STUDY of TRANSCAROTID ARTERY REVASCULARIZATION in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE. The ROADSTER 2 Study.
Lead sponsor
Silk Road Medical
Phase
Observational
Overall status
Completed
Start date
October 23, 2015
Completion date
April 29, 2019
Enrollment
692 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

carotid artery disease